Study Evaluating Efficacy and Safety of SAR566658 Treatment in Patients With CA6 Positive Metastatic Triple Negative Breast Cancer

NCT02984683 · clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
23
Enrollment
INDUSTRY
Sponsor class

Stopped Study discontinued considering the limited clinical benefit combined with a higher than expected rate of known non-serious ophthalmological event.

Conditions

Interventions

Sponsor

Sanofi